BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36412977)

  • 1. The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significance.
    Brett VE; Lechevalier N; Trimoreau F; Dussiau C; Dimicoli-Salazar S; Coster L; Luquet I; Nadal N; Ribourtout B; Chapiro E; Lefebvre C; Tondeur S; Balducci E; Nguyen-Khac F; Borie C; Radford-Weiss I; Barin C; Eclache V; Mansier O; Bidet A;
    Genes Chromosomes Cancer; 2023 Mar; 62(3):139-151. PubMed ID: 36412977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome.
    Choi EJ; Cho YU; Hur EH; Park HS; Choi Y; Lee JH; Lee KH; Kim M; Hwang SH; Jang S; Park CJ; Seo EJ; Lee JH
    Br J Haematol; 2022 Aug; 198(4):703-712. PubMed ID: 35612271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of Myelodysplastic Syndrome in Patients Evaluated for Cytopenia(s). A Report from a Reference Centre in Saudi Arabia.
    AlMozain N; Mashi A; Alneami Q; Al-Omran A; Bakshi N; Owaidah T; Khalil S; Khogeer H; Hashmi S; Al-Sweedan S; Morris T; AlNounou R
    Hematol Oncol Stem Cell Ther; 2022 Jun; 15(2):39-44. PubMed ID: 33227261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The International Consensus Classification of myelodysplastic syndromes and related entities.
    Hasserjian RP; Orazi A; Orfao A; Rozman M; Wang SA
    Virchows Arch; 2023 Jan; 482(1):39-51. PubMed ID: 36287260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.
    Jajosky AN; Sadri N; Meyerson HJ; Oduro KA; Kelkar A; Fitzgerald B; Tomlinson B; Moore EM; Beck RC
    Eur J Haematol; 2021 Apr; 106(4):500-507. PubMed ID: 33386622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study.
    Cargo C; Bernard E; Beinortas T; Bolton KL; Glover P; Warren H; Payne D; Ali R; Khan A; Short M; Van Hoppe S; Smith A; Taylor J; Evans P; Papaemmanuil E; Crouch S
    Lancet Haematol; 2024 Jan; 11(1):e51-e61. PubMed ID: 38135373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How I investigate Clonal cytogenetic abnormalities of undetermined significance.
    Tang G; Medeiros LJ; Wang SA
    Int J Lab Hematol; 2018 Aug; 40(4):385-391. PubMed ID: 29624895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome.
    Kaastrup K; Gillberg L; Mikkelsen SU; Ørskov AD; Schöllkopf C; Mortensen BK; Porse B; Hansen JW; Grønbæk K
    Clin Epigenetics; 2023 May; 15(1):91. PubMed ID: 37237325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance.
    Kwok B; Hall JM; Witte JS; Xu Y; Reddy P; Lin K; Flamholz R; Dabbas B; Yung A; Al-Hafidh J; Balmert E; Vaupel C; El Hader C; McGinniss MJ; Nahas SA; Kines J; Bejar R
    Blood; 2015 Nov; 126(21):2355-61. PubMed ID: 26429975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic, immunophenotypic, and molecular genetic comparison study in patients with clonal cytopenia of undetermined significance, myelodysplastic syndrome, and acute myeloid leukemia with myelodysplasia-related changes: A single institution experience.
    Gao L; Hyter S; Zhang D; Kelting S; Woodroof J; Abdallah AO; Yacoub A; McGuirk J; Abdelhakim H; Godwin AK; Cui W
    Int J Lab Hematol; 2022 Aug; 44(4):738-749. PubMed ID: 35352484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow Cytometric Findings in Clonal Cytopenia of Undetermined Significance.
    Nirmalanantham P; Sakhi R; Beck R; Oduro K; Gadde R; Ryder C; Yoest J; Sadri N; Meyerson HJ
    Am J Clin Pathol; 2022 Feb; 157(2):219-230. PubMed ID: 34542558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Lower Frequency of Spliceosome Mutations Distinguishes Clonal Cytopenias of Undetermined Significance From Low-Risk Myelodysplastic Syndromes, Despite Inherent Similarities in Genomic, Laboratory, and Clinical Features.
    Ferrone CK; McNaughton AJM; Rashedi I; Ring B; Buckstein R; Tsui H; Rauh MJ
    Mod Pathol; 2023 Mar; 36(3):100068. PubMed ID: 36788103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.
    Hebeda KM; Tzankov A; Boudova L; Saft L; Hasserjian RP; de Boer M; Fend F; Orazi A; Leguit R
    Pathobiology; 2019; 86(1):62-75. PubMed ID: 29982244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution-a proof of principle study.
    Nann D; Rau A; Mahmutovic L; Steinhilber J; Meca V; Federmann B; Vogel W; Bonzheim I; Quintanilla-Martinez L; Fend F
    Virchows Arch; 2023 Dec; 483(6):835-845. PubMed ID: 37610626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies?
    Vobugari N; Heuston C; Lai C
    Clin Adv Hematol Oncol; 2022 Jun; 20(6):375-383. PubMed ID: 35731608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS/CCUS): A single-center analysis of 79 patients.
    Dimopoulos K; Hansen OK; Sjö LD; Saft L; Schjødt IM; Werner Hansen J; Grønbaek K
    Cytometry B Clin Cytom; 2020 May; 98(3):250-258. PubMed ID: 31479199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICUS/CCUS/CHIP: basics & beyond.
    Jain M; Tripathi A
    Expert Rev Hematol; 2017 Oct; 10(10):915-920. PubMed ID: 28832236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.